COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 1158: Articles 11571-11580  | Next

Internalizing Problems Before and During the COVID-19 Pandemic in Dutch Children and Adolescents with and without Pre-Existing Mental Health Problems
Fischer, K., Tieskens, J., Luijten, M., Zijlmans, J., van Oers, H., de Groot, R., van der Doelen, D., van Ewijk, H., Klip, H., van der Lans, R., de Meyer, R., van der Mheen, M., van Muilekom, M., Ruisch, H., Teela, L., van den Berg, G., Bruining, H., van der Rijken, R., Buitelaar, J., Hoekstra, P., Lindauer, R., Oostrom, K., Staal, W., Vermeiren, R., Cornet, R., Haverman, L., Bartels, M., Polderman, T., Popma, A.
10.1101/2021.10.05.21264160 — Posted: 2021-10-07
Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
Molteni, E., Sudre, C. H., Canas, L. S., Bhopal, S. S., Hughes, R. C., Chen, L., Deng, J., Murray, B., Kerfoot, E., Antonelli, M. S., Graham, M. S., Klaser, K., May, A., Hu, C., Capdevila Pujol, J., Wolf, J., Hammers, A., Spector, T. D., Ourselin, S., Modat, M., Steves, C., Absoud, M., Duncan, E. L.
10.1101/2021.10.06.21264467 — Posted: 2021-10-07
Detection and quantification of SARS-CoV-2 RNA in wastewater influent in relation to reported COVID-19 incidence in Finland
Tiwari, A., Lipponen, A., Hokajarvi, A.-M., Luomala, O., Sarekoski, A., Rytkonen, A., Osterlund, P., Al-Hello, H., Juutinen, A., Miettinen, I. T., Savolainen-Kopra, C., Pitkanen, T.
10.1101/2021.10.05.21264462 — Posted: 2021-10-07
A joint hierarchical model for the number of cases and deaths due to COVID-19 across the boroughs of Montreal
Michal, V., Vanciu, L., Schmidt, A. M.
10.1101/2021.10.06.21264645 — Posted: 2021-10-07
Detailed reconstruction of the Iranian COVID-19 epidemic reveals high attack rates of SARS-CoV-2 in several provinces
Ghafari, M., Karlinsky, A., Watson, O. J., Ferretti, L., Katzourakis, A.
10.1101/2021.10.04.21264540 — Posted: 2021-10-07 Discussion: Onsite
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Earnest, R., Uddin, R., Matluk, N., Renzette, N., Siddle, K. J., Loreth, C., Adams, G., Tomkins-Tinch, C., Petrone, M. E., Rothman, J. E., Breban, M. I., Koch, R. T., Billig, K., Fauver, J. R., Vogels, C. B. F., Turbett, S., Bilguvar, K., De Kumar, B., Landry, M. L., Peaper, D. R., Kelly, K., Omerza, G., Grieser, H., Meak, S., Martha, J., Dewey, H. H., Kales, S., Berenzy, D., Carpenter-Azevedo, K., King, E., Huard, R. C., Smole, S. C., Brown, C. M., Fink, T., Lang, A. S., Gallagher, G. R., Sabeti, P. C., Gabriel, S., MacInnis, B. L., New England Variant Investigation Team, , Tewhey, R., Adams, M. D., Park, D. J., Lemieux, J. E., Grubaugh, N. D.
10.1101/2021.10.06.21264641 — Posted: 2021-10-07 Discussion: Onsite
Characterizing the effective reproduction number during the COVID-19 epidemic: Insights from Qatar experience
Bsat, R., Chemaitelly, H., Coyle, P., Tang, P., Hasan, M. R., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Nasrallah, G. A., Benslimane, F., Al Khatib, H. A., YASSINE, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J., Ayoub, H. H.
10.1101/2021.10.07.21264599 — Posted: 2021-10-07
Comparison of MIS-C Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine related Myocarditis in Children
Patel, T., Kelleman, M., West, Z., Peter, A., Dove, M., Butto, A., Oster, M.
10.1101/2021.10.05.21264581 — Posted: 2021-10-07 Discussion: Onsite
Serum but not mucosal antibody responses are predicted by pre-existing SARS-CoV-2 spike cross-reactive CD4+ T cells following BNT162b2 vaccination in the elderly
Meyer-Arndt, L., Schwarz, T., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Guercan, K., Uyar-Aydin, Z., Mueller, M. A., Drosten, C., Paul, F., Sander, L. E., Demuth, I., Lauster, R., Giesecke-Thiel, C., Braun, J., Corman, V. M., Thiel, A.
10.1101/2021.10.05.21264545 — Posted: 2021-10-07
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naive and previously infected individuals
Al-Sadeq, D., Shurrab, F., Ismail, A., Amanullah, F. H., Thomas, S., Aldewik, N., Yassine, H. M., Abdul Rahim, H., Abu-Raddad, L. J., Nasrallah, G.
10.1101/2021.10.05.21264550 — Posted: 2021-10-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).